e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab?
Simona Soresi (Isleworth, United Kingdom), Neeraj Kohli, Kirsty Habibi-Parker, Haifa Lyster, Anna K. Reed, Martin Carby, Andre R. Simon, Aron F. Popov, Simona Soresi
Source:
International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Session:
Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Session type:
Poster Discussion
Number:
1786
Disease area:
Respiratory critical care, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Simona Soresi (Isleworth, United Kingdom), Neeraj Kohli, Kirsty Habibi-Parker, Haifa Lyster, Anna K. Reed, Martin Carby, Andre R. Simon, Aron F. Popov, Simona Soresi. LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab?. Eur Respir J 2015; 46: Suppl. 59, 1786
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19
ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment
Related content which might interest you:
LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment.
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Initial treatment with CsA-AZA versus FK506-MPA: Comparison of early outcomes after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001
Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx)
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Azathioprine discontinuation and medium and long term outcomes after lung transplantation
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Hypogammaglobulinemia in lung transplant candidates
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
LATE-BREAKING ABSTRACT: Prospective randomised pilot study to investigate the clinical effect of orally inhaled AP301 on treatment of primary graft dysfunction (PGD) in patients after primary lung transplantation (LuTX)
Source: International Congress 2015 – Predictors of lung transplant complications
Year: 2015
Immunosuppressive therapy after human lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105
Year: 2003
Infectious complications after lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193
Year: 2003
The effect of everolimus on lung function and renal status in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Treatment options in chronic GVHD and CLAD post lung transplantation
Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities
Year: 2016
Respiratory and renal functional evolutionary profiles after introduction of everolimus and minimizing doses of calcineurin inhibitors in lung transplant recipients, a descriptive observational study
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
Immunosuppressive therapy after human lung transplantation
Source: Eur Respir J 2004; 23: 159-171
Year: 2004
Effects of two immunosuppressive triple therapies on inflammatory cells in lung
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Everolimus as a treatment of Chronic Lung Alograft Rejection (CLAD) in lung transplantation.
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019
Effects of basiliximab and triple therapy on airway mucociliary clearance of rats
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Early sirolimus immunosuppression is safe in lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept